Drew Ranieri

Stock Analyst at Morgan Stanley

(0.85)
# 2288
Out of 5,370 analysts
175
Total ratings
36.36%
Success rate
-1.61%
Average return
21 Stocks
Name Action PT Current % Upside Ratings Updated
ORGO Organogenesis Holdin...
Maintains: Equal-Weight
4 6
3.25 84.62% 4 Mar 5, 2025
GMED Globus Medical
Upgrades: Overweight
83 100
58.89 69.81% 12 Dec 2, 2024
SYK Stryker
Upgrades: Overweight
370 445
376.8 18.1% 9 Dec 2, 2024
SIBN SI-BONE
Maintains: Overweight
21 19
17.91 6.09% 15 Aug 6, 2024
IART Integra Lifesciences
Maintains: Underweight
24 27
12.4 117.74% 13 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
6 8
5.74 39.37% 12 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
26 22
24.05 -8.52% 16 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
10 8
11.07 -27.73% 13 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
19 16
10.98 45.72% 8 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
75 83
20.59 300.68% 10 Dec 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
10 8
n/a n/a 11 Nov 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
42 38
19.05 99.48% 9 Nov 2, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
88 96
69.97 37.2% 10 May 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
28 26
12.21 112.94% 8 May 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
290 295
172.18 71.33% 2 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
236 280
121.02 131.37% 5 Jan 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
11 5
6.57 -23.9% 6 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
72 70
30.74 127.72% 4 Oct 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
62 54
n/a n/a 1 Jul 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
325 300
518.65 -42.16% 6 Apr 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
130 148
n/a n/a 1 Aug 2, 2021